- GSK Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
20-F/A Filing
GSK (GSK) 20-F/A2022 FY Annual report (foreign) (amended)
Filed: 17 Apr 23, 12:00am
Exhibit 13.1
Section 906 Certificate
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of GSK plc, a public limited company incorporated under English law (the “company”), does hereby certify, to such officer’s knowledge, that:
Amendment No. 1 to the Annual Report on Form 20-F for the year ended December 31, 2022 (the “Report”) of the company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the company.
Date: April 14, 2023 | /s/ Emma Walmsley | |||||
Emma Walmsley | ||||||
Chief Executive Officer | ||||||
Date: April 14, 2023 | /s/ Iain Mackay | |||||
Iain Mackay | ||||||
Chief Financial Officer |